DOLIVER ADVISORS, LP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 938077 HOUSTON, TX

Position in VRDN

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$551,100

New position

Shares Held

30,000

first reported quarter

Ownership

0.026%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#124

of 214 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

DOLIVER ADVISORS, LP holds $1,521,600 across 3 Biotechnology names. VRDN ranks #2 (36.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IBRX	ImmunityBio, Inc.	100,000	$875,500
2	VRDN	Viridian Therapeutics, Inc.\DE This page	30,000	$551,100
3	ONCY	Oncolytics Biotech Inc	100,000	$95,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$551,100	30,000	—	Shares	Sole	2026-07-10
No filing history on record for this holder in this stock.